HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sawant, D. Articles by Moghissi, K. Search for Related Content PubMed PubMed Citation Articles by Sawant, D. Articles by Moghissi, K.

European Journal of Cardio-Thoracic Surgery, Vol 8, 113-116, Copyright © 1994 by European Association for Cardio-thoracic Surgery

ARTICLES

Management of unresectable oesophageal cancer: a review of 537 patients

D Sawant and K Moghissi
Department of Cardiothoracic Surgery, Castle Hill Hospital, Cottingham, Hull, UK.

We compared and contrasted the potentials of palliation afforded by various management methods in a retrospective study of all patients referred to one surgical team in a 20-year period. Five hundred thirty- seven patients had unresectable oesophageal cancer. There were five treatment groups: group 1-dilatation plus external radiotherapy (DXR, n = 95), group 2-gastrostomy plus DXR (n = 18), group 3-permanent intubation (n = 329), group 4-oesophageal bypass (BP, n = 70), and group 5-YAG laser plus brachytherapy (n = 25). Groups 1 and 2 had high mortality (4% and 25%) and poor symptom relief, with an average survival of 2.5 and 3.5 months, respectively. Group 3 had a 20% mortality rate, moderate-to-good symptom relief and an average survival of 4.2 months. This method was best for lower oesophageal cancer. Group 4 had a 22% mortality rate, good symptom relief and an average survival of 10.5 months. The BP method was suitable for patients with oesophago- airway fistula (OAF) and those with lower oesophageal cancer found unresectable at operation. Group 5 had a hospital mortality rate of 8%, good symptom control and an average survival of 6.2 months. This was suitable for all patients (except those with OAF). In palliation of carcinoma of the oesophagus the selection of method should be made to suit the characteristic and location of the tumour.

This article has been cited by other articles:

				W H Allum, S M Griffin, A Watson, and D Colin-Jones Guidelines for the management of oesophageal and gastric cancer Gut, June 1, 2002; 50 (2007): v1 - v23. [Full Text] [PDF]

				K. Moghissi, K. Dixon, J. A. C. Thorpe, M. Stringer, and P. J. Moore The role of photodynamic therapy (PDT) in inoperable oesophageal cancer Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 95 - 100. [Abstract] [Full Text] [PDF]